← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 23, 2022Last known activity
May 31, 2025
Timeline
2010s
- Jan 1, 2017
Tango Therapeutics, Inc.— Founded
Drugs by trial phase (10 distinct, 6 trials)
Phase 2 (10 own, 0 via acquisition)
Recent trials (12)
- NCT06922591Lead sponsorPhase 1/Phase 2May 31, 2025
- NCT06922591OfficialPhase 1/Phase 2May 31, 2025
- NCT06810544Lead sponsorPhase 1/Phase 2Mar 24, 2025
- NCT06810544OfficialPhase 1/Phase 2Mar 24, 2025
- NCT06065059Lead sponsorPhase 1/Phase 2Dec 8, 2023
- NCT06065059Study directorPhase 1/Phase 2Dec 8, 2023
- NCT05887492Lead sponsorPhase 1/Phase 2Jun 12, 2023
- NCT05887492Study directorPhase 1/Phase 2Jun 12, 2023
- NCT05732831Study directorPhase 1/Phase 2May 26, 2023
- NCT05732831Lead sponsorPhase 1/Phase 2May 26, 2023
- NCT05275478Lead sponsorPhase 1/Phase 2Mar 23, 2022
- NCT05275478Study directorPhase 1/Phase 2Mar 23, 2022
Details
- Founded
- Boston, MA, US Jan 1, 2017
- Last known activity
- May 31, 2025